Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00802984 · ClinicalTrials.gov registry record · Phase 4
Endovascular Repair of Descending Thoracic Aortic Aneurysms
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT00802984: Completed Phase 4 study, sponsored by Stanford University.
NCT00802984 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00802984, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the system is safe and effective for the intended use of treating descending thoracic aortic aneurysms.
Interventions
- DEVICE Endovascular thoracic aortic aneurysm repair using TALENT TAA Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2002-01 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00802984
The ClinicalTrials.gov registry entry for NCT00802984 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endovascular thoracic aortic aneurysm repair using TALENT TAA Stent Graft System is the first listed.
NCT00802984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00802984 about?
NCT00802984 is a clinical study titled "Endovascular Repair of Descending Thoracic Aortic Aneurysms". The purpose of this study is to determine whether the system is safe and effective for the intended use of treating descending thoracic aortic aneurysms.
What is the current status of trial NCT00802984?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2002-01. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00802984?
The interventions under investigation include: Endovascular thoracic aortic aneurysm repair using TALENT TAA Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT00802984?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.